| A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients MM Ahamad, S Aktar, M Rashed-Al-Mahfuz, S Uddin, P Liò, H Xu, ... Expert systems with applications 160, 113661, 2020 | 165 | 2020 |
| TClustVID: A novel machine learning classification model to investigate topics and sentiment in COVID-19 tweets MS Satu, MI Khan, M Mahmud, S Uddin, MA Summers, JMW Quinn, ... Knowledge-Based Systems 226, 107126, 2021 | 101 | 2021 |
| A deep convolutional neural network method to detect seizures and characteristic frequencies using epileptic electroencephalogram (EEG) data M Rashed-Al-Mahfuz, MA Moni, S Uddin, SA Alyami, MA Summers, ... IEEE journal of translational engineering in health and medicine 9, 1-12, 2021 | 94 | 2021 |
| Pathogenetic profiling of COVID-19 and SARS-like viruses Z Nain, HK Rana, P Liò, SMS Islam, MA Summers, MA Moni Briefings in bioinformatics 22 (2), 1175-1196, 2021 | 59 | 2021 |
| Skeletal muscle and motor deficits in Neurofibromatosis Type 1 MA Summers, KG Quinlan, JM Payne, DG Little, KN North, A Schindeler Journal of musculoskeletal & neuronal interactions 15 (2), 161, 2015 | 58 | 2015 |
| Lipid storage myopathies: Current treatments and future directions ER Vasiljevski, MA Summers, DG Little, A Schindeler Progress in lipid research 72, 1-17, 2018 | 47 | 2018 |
| Machine learning approaches to identify patient comorbidities and symptoms that increased risk of mortality in COVID-19 S Aktar, A Talukder, MM Ahamad, AHM Kamal, JR Khan, ... Diagnostics 11 (8), 1383, 2021 | 42 | 2021 |
| Cancer cell dormancy in metastasis MA Summers, MM McDonald, PI Croucher Cold Spring Harbor Perspectives in Medicine 10 (4), a037556, 2020 | 41 | 2020 |
| The multiple faces of tryptophan in bone biology A Al Saedi, S Sharma, MA Summers, K Nurgali, G Duque Experimental Gerontology 129, 110778, 2020 | 34 | 2020 |
| Tumor cell dormancy and reactivation in bone: skeletal biology and therapeutic opportunities NM Byrne, MA Summers, MM McDonald JBMR plus 3 (3), e10125, 2019 | 34 | 2019 |
| Dietary intervention rescues myopathy associated with neurofibromatosis type 1 MA Summers, T Rupasinghe, ER Vasiljevski, FJ Evesson, K Mikulec, ... Human molecular genetics 27 (4), 577-588, 2018 | 30 | 2018 |
| Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease MA Moni, JMW Quinn, N Sinmaz, MA Summers Briefings in bioinformatics 22 (2), 1324-1337, 2021 | 28 | 2021 |
| Inducible cell labeling and lineage tracking during fracture repair T Seime, M Kolind, K Mikulec, MA Summers, L Cantrill, DG Little, ... Development, growth & differentiation 57 (1), 10-23, 2015 | 17 | 2015 |
| L‐carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial ER Vasiljevski, J Burns, P Bray, G Donlevy, AJ Mudge, KJ Jones, ... American Journal of Medical Genetics Part A 185 (10), 2976-2985, 2021 | 10 | 2021 |
| Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1) ER Vasiljevski, PJ Houweling, T Rupasinghe, T Kaur, MA Summers, ... Plos one 15 (8), e0237097, 2020 | 8 | 2020 |
| Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse MA Summers, ER Vasiljevski, K Mikulec, L Peacock, DG Little, ... Molecular Genetics and Metabolism 123 (4), 518-525, 2018 | 8 | 2018 |
| Limitations of the Pax7-creERT2 transgene for driving deletion of Nf1 in adult mouse muscle MA Summers, K Mikulec, L Peacock, DG Little, A Schindeler International Journal of Developmental Biology 61 (8-9), 531-536, 2017 | 4 | 2017 |
| DIETARY TREATMENT FOR NEUROFIBROMATOSIS TYPE 1 DA Stevenson, MA Summers, B Johnson, C Murray, H Hanson, A Stevens, ... AMERICAN JOURNAL OF MEDICAL GENETICS PART A 179 (4), 701-701, 2019 | | 2019 |
| Evaluating modified diets and dietary supplement therapies for reducing muscle lipid and improving muscle function in neurofibromatosis type 1 (NF1) A Schindeler, E Vasiljevski, T Rupasinghe, U Roessner, M Summers, ... OSF, 2018 | | 2018 |
| Molecular Analysis of Neurofibromin Deficient Muscle MA Summers | | 2017 |
